Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States
- PMID: 34213561
- PMCID: PMC8254130
- DOI: 10.1001/jamanetworkopen.2021.15653
Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States
Abstract
This cross-sectional study evaluates measures of health equity in COVID-19 vaccination plans in the 50 US states and Washington, DC.
Conflict of interest statement
Figures
References
-
- US Food and Drug Administration . FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 Vaccine. U.S. Food and Drug Administration. December 11, 2020. Accessed April 19, 2021. https://www.fda.gov/news-events/press-announcements/fda-takes-key-action...
-
- US . COVID-19 vaccination program interim playbook for jurisdiction operations. October 29, 2020. Accessed January 31, 2021. https://www.cdc.gov/vaccines/imz-managers/downloads/COVID-19-Vaccination...
-
- Farroni JS, Tumilty E, Mukherjee D, McCammon S, Chooljian DM, Eves MM. Emerging roles of clinical ethicists. J Clin Ethics. 2019;30(3):262-269. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
